Age/disease duration influence on activities of daily living and quality of life after levodopa-carbidopa intestinal gel in Parkinson's disease. [electronic resource]
- Neurodegenerative disease management 06 2018
- 161-170 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1758-2032
10.2217/nmt-2017-0046 doi
Activities of Daily Living Age Factors Aged Antiparkinson Agents--administration & dosage Carbidopa--administration & dosage Drug Combinations Europe Female Gels--therapeutic use Humans International Cooperation Intestines--physiology Levodopa--administration & dosage Male Middle Aged Parkinson Disease--drug therapy Quality of Life Surveys and Questionnaires Treatment Outcome